Expression of prostaglandin endoperoxide H synthase-2 induced by nitric oxide in conditionally immortalized murine colonic epithelial cells

FASEB Journal

Volumn 14, Issue 9, 2000, Pages 1188-1201

  Mei, Jay M ^a   Hord, Norman G ^a,c   Winterstein, Dolores F ^b   Donald, Steven P ^a   Phang, James M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c Michigan State University   (United States)

Author keywords

Colonic epithelial cells; Nitric oxide; NOS II; PGHS 2

Indexed keywords

NITRIC OXIDE; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ARTICLE; CELL IMMORTALIZATION; COLON MUCOSA; CONTROLLED STUDY; DNA PROTEIN COMPLEX; ELECTROPHORETIC MOBILITY; ENZYME SYNTHESIS; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION;

EID: 0034038977     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.14.9.1188     Document Type: Article

References (62)

1. Singer, I. I., Kawka, D. W., Schloemann, S., Tessner, T., Richl, T., and Stenson, W. F. (1998) Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 115, 297-306
2. Hendel, J., and Nielsen, O. H. (1997) Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease. Am. J. Gastroenterol. 92, 1170-1173
3. Kutchera, W., Jones, D. A., Matsunami, N., Groden, J., McIntyre, T. M., Zimmerman, G. A., White, R. L., and Prescott, S. M. (1996) Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc. Natl. Acad. Sci. USA 93, 4816-4820
4. DuBois, R. N., Radhika, A., Reddy, B. S., and Entingh, A. J. (1996) Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 110, 1259-1262
5. Williams, C. S., Luougo, C., Radhika, A., Zhang, T., Lamps, L. W., Nanney, L. B, Beachamp, R. D., and DuBois, R. N. (1996) Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology 111, 1134-1140
6. Tsujii, M., Kawano, S., and DuBois, R. N. (1997) Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. USA 94, 3336-3340
7. Jacoby, R. F., Marshall, D. J., Newton, M. A., Novakovic, K., Tutsch, K., Cole, C. E., Lubet, R. A., Kelloff, G. J., Verma, A., Moser, A. R., and Dove, W. F. (1996) Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res. 56, 710-714
8. Boolbol, S. K., Dannerberg, A. J., Chadburn, A., Martucci, C., Guo, X., Ramonetti, J. T., Abreu-Goris, M., Newmark, H. L., Lipkin, M. L., DeCosse, J. J., and Bertagnolli, M. M. (1996) Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res. 56, 2556-2560
9. Subbaramaiah, K., Zakim, D., Weksler, B. B., and Dannenberg, A. J. (1997) Inhibition of cyclooxygenase: a novel approach to cancer prevention. Proc. Soc. Exp. Biol. Med. 216, 201-210
10. Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., and Taketo, M. M. (1996) Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase-2. Cell 87, 803-809
11. Tsujii, M., and DuBois, R. N. (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83, 493-501
12. Sheng, H., Shao, J., Morrow, J. D., Beauchamp, R. D., and DuBois, R. N. (1998) Bcl-2 expression by prostaglandin E2 in modulation of apoptosis human colon cancer cells. Cancer Res. 58, 362-366
13. Kinzler, K. W., and Vogelstein, B. (1996) Lessons from hereditary colorectal cancer. Cell 87, 159-170
14. Groden, J., Thliveris, A., Samowitz, W., Carlson, M., Gelbert, L., Albertsen, H., Josyln, G., Stevens, J., Spirio, L., Robertson, M., Sargeant, L., Krapcho, K., Wolff, E., Burt, R., Hughes, J. P., Warrington, J., McPherson, J. P., Wasmuth, J., Paslier, D. L., Abderrahim, H., Cohen, D., Leppert, M., and White, R. (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66, 589-600
15. Oshima, M., Oshima, H., Kitagawa, K., Kobayashi, M., Itakura, C., and Taketo, M. (1995) Loss of Ape heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc. Natl. Acad. Sci. USA 92, 4482-4486
16. Moser, A. R., Luongo, C., Gould, K. A., McNeley, M. K., Shoemaker, A. R., and Dove, W. F. (1995) ApcMin: a mouse model for intestinal and mammary tumorigenesis. Eur. J. Cancer 31, 1061-1066
17. Munemitsu, S., Albert, I., Souza, B., Rubinfeld, B., and Polakis, P. (1995) Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc. Natl. Acad. Sci. USA 92, 3046-3050
18. Morin, P. J., Sparks, A. B., Krinek, V., Barker, N., Clevers, H., Vogelstein, B., and Kinzler, K. W. (1997) Activation of beta-cateni-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275, 1787-1790
19. Prescott, S. M., and White, R. L. (1996) Self-promotion? Intimate connections between APC and prostaglandin H synthase-2. Cell 87, 783-786
20. Howe, L. R., Subbaramaiah, K., Chung, W. J., Dannenberg, A. J., and Brown, A. M. C. (1999) Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells. Cancer Res. 59, 1572-1577
21. ter Steege, J., Buurman, W., Arends, J. W., and Forget, P. (1997) Presence of inducible nitric oxide synthase, nitrotyrosine, CD68, and CD14 in the small intestine in celiac disease. Lab. Invest. 77, 29-36
22. Singer, I. I., Kawka, D. W., Scott, S., Weidner, J. R., Mumford, R. A., Riehl, T. E., and Stenson, W. F. (1996) Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 111, 871-885
23. Ambs, S., Merriam, W. G., Bennett, W. P., Felley-Bosco, E., Ogunfusika, M. O., Oser, S., Klein, S., Shields, P. G., Billiar, T. R., and Harris, C. C. (1998) Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 58, 334-341
24. Salvemini, D., Misko, T. P., Masferrer, J. L., Seibert, K., Currie, M. G., and Needleman, P. (1993) Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci., USA 90, 7240-7244
25. von Knethen, A., and Brune, B. (1997) Cyclooxygenase-2: an essential regulator of NO-mediated apoptosis. FASEB J. 11, 887-895
26. Landino, L. M., Crews, B. C., Timmons, M. D., Morrows, J. D., and Marnett, L. J. (1996) Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc. Natl. Acad. Sci. USA 93, 15069-15074
27. Salvemini, D. (1997) Regulation of cyclooxygenase enzymes by nitric oxide. Cell. Mol. Life Sci. 53, 576-582
28. Whitehead, R. H., and Joseph, J. L. (1994) Derivation of conditionally immortalized cell lines containing the Min mutation from the normal colonic mucosa and other tissues of an "Immortomouse"/Min hybrid. Epith. Cell Biol. 3, 119-125
29. Whitehead, R. H., VanEeden, P. E., Nobel, M. D., Ataliotis, P., and Jat, P. S. (1993) Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice. Proc. Natl. Acad. Sci. USA 90, 587-591
30. Mei, J. M., Hord, N. G., Winterstein, D. F., Donald, S. P., and Phang, J. M. (1999) Differential expression of prostaglandin endoperoxide H synthase-2 and formation of activated betacatenin-LEF-1 transcription complex in mouse colonic epithelial cells contrasting in Apc. Carcinogenesis 20, 737-740
31. D'Abaco, G. M., Whitehead, R. H., and Burgess, A. W. (1996) Synergy between Apc min and an activated ras mutation is sufficient to induce colon carcinomas. Mol. Cell. Biol. 3, 884-891
32. Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489
33. Sakanaka, C., Weiss, J. B., and Williams, L. T. (1998) Bridging of beta-catenin and glycogen synthase kinase-3 beta by axin and inhibition of beta-catenin-mediated transcription. Proc. Natl. Acad. Sci. USA 95, 3020-3023
34. Rubinfeld, B., Souza, B., Albert, I., Muller, O., Chamberlain, S. H., Masiarz, F. R., Munemitsu, S., and Polakis, P. (1993) Association of the Apc gene product with beta-catenin. Science 262, 1731-1734
35. Korinek, V., Barker, N., Morin, P. J., Van Wichen, D., De Weger, R., Kinzler, K. W., Vogelstein, B., and Clevers, H. (1997) Constitutive transcriptional activation by beta-catenin-Tcf complex in APC-/-colon carcinoma. Science 275, 1784-1787
36. Kinzler, K. W., and Vogelstein, B. (1997) Cancer-susceptibility gene: gatekeepers and caretakers. Nature (London) 386, 761-762
37. Rubinfeld, B., Albert, I., Porfiri, E., Munemitsu, S., and Polakis, P. (1997) Loss of beta-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene. Cancer Res. 57, 4624-4630
38. Porfiri, E., Rubinfeld, B., Albert, I., Hovanes, K., Waterman, M., and Polakis, P. (1997) Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutations of beta-catenin. Oncogene 15, 2833-2839
39. Shoemaker, A. R., Luongo, C., Moser, A. R., Marton, L. J., and Dove, W. F. (1997) Somatic mutational mechanisms involved in intestinal tumor formation in Min mice. Cancer Res. 57, 1999-2006
40. Shoemaker, A. R., Gould, K. A., Luongo, C., Moser, A. R., and Dove, W. F. (1997) Studies of neoplasia in the Min mouse. Biochim. Biophys. Acta 1332, F25-F48
41. Moser, A. R., Pitot, H. C., and Dove, W. F. (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247, 322-324
42. Jacoby, R. F., Marshall, D. J., Kailas, S., Schlack, S., Harms, B., and Love, R. (1995) Genetic instability associated with adenoma to carcinoma progression in hereditary nonpolyposis colon cancer. Gastroenterology 109, 73-82
43. Behrens, J., Von Kries, J. P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and Birchmeier, W. (1996) Functional interaction of beta-catenin with the transcription factor LEF-1. Nature (London) 382, 638-642
44. Huber, O., Korn, R., McLaughlin, J., Ohsugi, M., Herrmann, B. G., and Kemler, R. (1996) Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mech. Dev. 59, 3-10
45. Peifer, M. (1997) Beta-catenin as oncogene: the smoking gun. Science 275, 1752-1753
46. Muller, T., Choidas, A., Reichmann, E., and Ullrich, A. (1999) Phosphorylation and Free pool of beta-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration. J. Biol. Chem. 274, 10173-10183
47. Kuroda, S., Fukata, M., Nakagawa, M., Fujii, K., Nakamura, T., Ookubo, T., Izawa, I., Nagase, T., Nomura, N., Tani, H., Shoji, I., Matsuura, Y., Yonehara, S., and Kaibuchi, K. (1998) Role of IQGAP1, a target of the small GTPases Cdc42 and Rac1, in regulation of E-cadherin-mediated cell-cell adhesion. Science 281, 832-835
48. Ryuto, M., Jimi, S., Ono, M., Naito, S., Nakayama, Y., Yamada, Y., Komiyama, S., and Kuwano, M. (1997) All-trans-retinoic acid-dependent inhibition of E-cadherin-based cell adhesion with concomitant dephosphorylation of beta-catenin in metastatic human renal carcinoma cells. Jpn. J. Cancer Res. 88, 982-991
49. Aberle, H., Schwarts, H., and Kemler, R. (1996) Cadherin-catenin complex: protein interactions and their implications for cadherin function. J. Cell. Biohem. 61, 514-523
50. Barth, A. I., Nathke, I. S., and Nelson, W. J. (1997) Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. Curr. Opin. Cell Biol. 9, 683-690
51. Melillo, G., Musso, T., Sica, A. Taylor, L. S., Cox, G. W., and Varesio, L. (1995) A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J. Exp. Med. 182, 1683-1693
52. Schmedtje, J. F., Yan-Shan, J., Liu, W. L., DuBois, R. N., and Runge, M. S. (1997) Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J. Biol. Chem. 272, 601-608
53. MacMicking, J., Xie, Q., and Nathan, C. (1997) Nitric oxide and macrophage function. Annu. Rev. Immunol. 15, 323-350
54. Thomsen, L. L., Scott, J. M., Topley, P., Knowles, R. G., Keerie, A. J., and Frend, A. J. (1997) Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res. 57, 3300-3304
55. Rao, C. V., Kawamori, T., Hamid, R., and Reddy, S. (1999) Chemoprevention of colonie aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis 20, 641-644
56. Brouet, I., and Ohshima, H. (1995) Curcumin, an anti-tumor promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem. Biophys. Res. Commun. 206, 533-540
57. Rao, C. V., Rivenson, A., Simi, B., and Reddy, B. S. (1995) Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res. 55, 259-266
58. Ohshima, H., and Bartsch, H. (1994) Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res. 305, 253-264
59. Liu, J. H., and Hotchkiss, R. H. (1995) Potential genotoxicity of chronically elevated nitric oxide: a review. Mutat. Res. 339, 73-89
60. Lander, H. M., Jacovina, A. T., Davis, R. J., and Tauras, J. M. (1996) Differential activation of mitogen-activated protein kinases by nitric oxide-related species. J. Biol. Chem. 271, 19705-19709
61. Herschman, H. R. (1996) Prostaglandin synthase-2. Biochim. Biophys. Acta 1299, 125-140
62. DuBois, R. N., Shao, J., Tsujii, M., Sheng, H., and Beauchamp, D. (1996) G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res. 56, 733-737